Algernon Pharmaceuticals Stock Price Prediction
| AGNPF Stock | USD 0.06 0.01 12.55% |
Oversold Vs Overbought
43
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Algernon Pharmaceuticals based on different types of headlines from major news networks to social media. Using Algernon Pharmaceuticals hype-based prediction, you can estimate the value of Algernon Pharmaceuticals from the perspective of Algernon Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Algernon Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Algernon Pharmaceuticals to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Algernon because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Algernon Pharmaceuticals after-hype prediction price | USD 0.06 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Algernon |
Algernon Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Algernon Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Algernon Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Algernon Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Algernon Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Algernon Pharmaceuticals' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Algernon Pharmaceuticals' historical news coverage. Algernon Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 10.48, respectively. We have considered Algernon Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Algernon Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Algernon Pharmaceuticals is based on 3 months time horizon.
Algernon Pharmaceuticals OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Algernon Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Algernon Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Algernon Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 10.42 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.06 | 0.06 | 4.53 |
|
Algernon Pharmaceuticals Hype Timeline
Algernon Pharmaceuticals is presently traded for 0.06. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Algernon is projected to increase in value after the next headline, with the price projected to jump to 0.06 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is projected to be 4.53%, whereas the daily expected return is presently at 0.07%. The volatility of related hype on Algernon Pharmaceuticals is about 416800.0%, with the expected price after the next announcement by competition of 0.06. Algernon Pharmaceuticals has accumulated about 872.84 K in cash with (2.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Assuming the 90 days horizon the next projected press release will be in 5 to 10 days. Check out Algernon Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Algernon Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Algernon Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Algernon Pharmaceuticals' future price movements. Getting to know how Algernon Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Algernon Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| VGLS | Vg Life Sciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ADAG | Adagene | (0.01) | 6 per month | 0.00 | (0.03) | 8.13 | (9.52) | 37.93 | |
| MRZM | Marizyme | 0.00 | 0 per month | 9.60 | 0.07 | 25.00 | (20.00) | 128.57 | |
| MYMX | Mymetics Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Algernon Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Algernon price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Algernon using various technical indicators. When you analyze Algernon charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Algernon Pharmaceuticals Predictive Indicators
The successful prediction of Algernon Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Algernon Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Algernon Pharmaceuticals based on analysis of Algernon Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Algernon Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Algernon Pharmaceuticals's related companies.
Story Coverage note for Algernon Pharmaceuticals
The number of cover stories for Algernon Pharmaceuticals depends on current market conditions and Algernon Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Algernon Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Algernon Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Algernon Pharmaceuticals Short Properties
Algernon Pharmaceuticals' future price predictability will typically decrease when Algernon Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Algernon Pharmaceuticals often depends not only on the future outlook of the potential Algernon Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Algernon Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.4 M |
Complementary Tools for Algernon OTC Stock analysis
When running Algernon Pharmaceuticals' price analysis, check to measure Algernon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Algernon Pharmaceuticals is operating at the current time. Most of Algernon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Algernon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Algernon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Algernon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |